Skip to main content
DAVA
NYSE Technology

Endava to Restate FY26 Revenue After Accounting Probe; CFO and GC Out

Tom Rudovsky · Reported by Wiseek News
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
9
Price
$1.96
Mkt Cap
$110.169M
52W Low
$1.6
52W High
$9.88
52W Position info
22% above low
Off High info
80% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

DAVA sits 22% above its 52-week low of $1.6 on light trading volume (0.3× avg).

Summary

Endava will restate FY26 results after an audit probe found improper accounting on certain customer and supplier deals, with revenue adjustments preliminarily estimated at roughly 2%-4% of prior FY25 revenue, though it does not expect to restate any prior fiscal years or any periods within those years. The company had roughly £55 million cash as of September 30, 2026. It expects material weaknesses in internal controls, has withdrawn FY26 guidance and delayed its 20-F filing. CFO Mark Thurston resigned October 25 and the General Counsel is also out; John Cotterell is to retire from his role as Chief Executive Officer, and Rob Machin will be appointed as interim CEO, taking over November 2. This escalates the September disclosure that Thurston was placed on administrative leave after auditors raised accounting concerns — the problem is now quantified and the leadership exits are confirmed. For a company of this size, a restatement of that magnitude plus a late 20-F and withdrawn guidance hits credibility, lender covenants and near-term estimates at once. The next hard data point is the finalized audited figures and a remediation timeline.

Updated with an SEC 6-K filing · What changed

Updates

  1. · SEC 6-K — Endava preliminarily estimates FY26 revenue adjustments of about 2%-4% of prior FY25 revenue and had roughly £55 million cash as of September 30, 2026.

At the time of this announcement, DAVA was trading at $1.96 on NYSE in the Technology sector, with a market capitalization of approximately $110.2M. The 52-week trading range was $1.60 to $9.88. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

DAVA - Latest Insights

DAVA
Oct 28, 2026, 8:26 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.94
Real-time Price: $1.91 info
Change: -$0.030 (-2%) info
Market Cap: $110.169M info
DAVA
Oct 07, 2026, 8:22 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.90
Real-time Price: $1.91 info
Change: +$0.010 (+0.53%) info
Market Cap: $110.169M info
DAVA
Sep 22, 2026, 6:19 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.42
Real-time Price: $1.91 info
Change: -$0.510 (-21%) info
Market Cap: $110.169M info
DAVA
Sep 21, 2026, 5:06 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.78
Real-time Price: $1.91 info
Change: -$0.870 (-31%) info
Market Cap: $110.169M info
DAVA
Sep 21, 2026, 5:04 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.79
Real-time Price: $1.91 info
Change: -$0.880 (-32%) info
Market Cap: $110.169M info